CBIO Catalyst Biosciences Inc

Catalyst Biosciences Inc is a clinical-stage biopharmaceutical company. The Company is engaged in creating and developing novel medicines to address serious medical conditions.

As of 04/09/2021     IEX book   CBOE book

Security Information
Category1:  US Equity
Category2:  Common stocks
Category3:  Micro cap
GICS sector:  Health Care
Industry:  Biotechnology
Index country:  USA
Country of incorporation:  USA
IPO date:  04/12/2006
Outstanding shares:  31,331,027
Average volume:  333,294
Market cap:   $160,101,548
Current dividend yield:  0.00%
All SEC filings:     SEC Edgar Online
Quarterly filings:   10-Q
Annual filings:      10-K
CUSIP:    14888D208
ISIN:        US14888D2080
Sedol:      BYZ1F99
Valuation   (See tab for details)
PE ratio:   -2.85
PB ratio:   1.20
PS ratio:   7.64
Return on equity:   -73.93%
Net income %:   -268.48%

2021 © Stock Market MBA, Inc. Terms of use | Privacy policy